MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0162331
Litman Pharmaceuticals Private Limited
Litman Pharmaceuticals Private Limited - chemicals in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.68 Lakh
▲ 59% YoY
Net loss · FY 2024
₹18,506
Net margin -2.1%
EBITDA · FY 2024
-₹12,661
EBITDA margin -1.5%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Litman Pharmaceuticals Private Limited
Data last updated:
Litman Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC082869. Its GSTIN is 32AACCL9321L1ZH (Kerala).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Sanil (Managing Director) and Ardra Vijayan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.68 Lakh, a growth of 59% compared to the previous year. For the same year it recorded a net loss of ₹18,506 (net margin -2.1%) and EBITDA of -₹12,661 (EBITDA margin -1.5%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
Litman Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0162331). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230KA2015PTC082869
Registration Number 082869
Incorporation Date 15 September 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0162331
Recognitions & Rankings of Litman Pharmaceuticals
Contact details
Litman Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo.415 C/O. Muniraj Reddy Building Govindashetty – Palya Konnappana Agrahara Electronic Cit, Y, Bangalore, Karnataka, India – 560100
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Litman Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Litman Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Litman Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Litman Pharmaceuticals Private Limited, buy the company report.
Financials of Litman Pharmaceuticals Private Limited
FY 2024 filings availableLitman Pharmaceuticals Private Limited reported revenue of ₹8.68 Lakh (up 59% YoY) for FY 2024.
Revenue · FY 2024
₹8.68 Lakh ▲ 59%
Net loss · FY 2024
₹18,506 margin -2.1%
EBITDA · FY 2024
-₹12,661 margin -1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 59%
3 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 47%
5 years · compounded
▼ 36%
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 59% growth in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12,661 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹18,506 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.5% | ||||
| Net Profit Margin | -2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Litman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Litman Pharmaceuticals Private Limited
Litman Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ardra Vijayan | Director | 30 Jun 2021 | 5 Years 3 Months | Current |
| Abhishek Mudoor Also directs: Policygram LLP | Director | 30 Jun 2021 | 5 Years 3 Months | Current |
| Midhun Raj V C | Director | 30 Jun 2021 | 5 Years 3 Months | Current |
| Sanil | Managing Director | 15 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Litman Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nordisk Pharmaceuticals Private Limited | ₹8.73 Lakh (FY 2023) | 16.0% | Rewa, Madhya Pradesh, India | |||
| Glowchem Pharmaceuticals Private Limited | ₹8.7 Lakh (FY 2016) | 10.0% | Gopalganj, Bihar, India | |||
| Litman Pharmaceuticals Private Limitedthis company | ₹8.68 Lakh (FY 2024) | -₹18,506 | -2.1% | 59.0% | Bangalore, Karnataka, India | |
| Delvizant Pharmaceuticals Private Limited | ₹8.67 Lakh (FY 2022) | -21.0% | Lucknow, Uttar Pradesh, India | |||
| Orka Pharmaceuticals Private Limited | ₹8.66 Lakh (FY 2024) | 498.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Litman Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Litman Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Litman Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Litman Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AACCL9321L1ZH | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Litman Pharmaceuticals Private Limited, buy the company report.
Recent activity
Litman Pharmaceuticals Private Limited has 7 board changes on record since 2015: 4 appointments and 3 cessations. The latest: Abhishek Mudoor was appointed as Director on 30 Jun 2021.
AGM
Litman Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Litman Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Appointed
Abhishek Mudoor was appointed as Director.
Appointed
Ardra Vijayan was appointed as Director.
Ceased
Gopalan ceased to be Director.
Appointed
Midhun Raj V C was appointed as Director.
Ceased
Liju Kannankunnummal ceased to be Director.
Appointed
Sanil was appointed as Managing Director.
Ceased
Sanil ceased to be Director.
Incorporation
15 Sep 2015
Litman Pharmaceuticals Private Limited was registered on 15 Sep 2015 with Roc Bangalore & aged 11 years 1 month as per MCA records.
Frequently asked questions
Litman Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 15 September 2015 (11+ years old) and is registered under CIN U24230KA2015PTC082869.
Litman Pharmaceuticals has 4 current directors:
- Sanil - Managing Director
- Ardra Vijayan - Director
- Abhishek Mudoor - Director
- Midhun Raj V C - Director
The latest financial statements of Litman Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Litman Pharmaceuticals is 32AACCL9321L1ZH, registered in Kerala.
The CIN (Corporate Identification Number) of Litman Pharmaceuticals is U24230KA2015PTC082869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Litman Pharmaceuticals was incorporated on 15 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Litman Pharmaceuticals by revenue are Nordisk Pharmaceuticals Private Limited, Glowchem Pharmaceuticals Private Limited, Delvizant Pharmaceuticals Private Limited, Orka Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhishek Mudoor was appointed as Director on 30 Jun 2021. Ardra Vijayan was appointed as Director on 30 Jun 2021. Gopalan ceased to be Director on 30 Jun 2021. Litman Pharmaceuticals has 7 board changes on record in total.
Yes, Litman Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0162331).
The registered office of Litman Pharmaceuticals is at No.415 CO. Muniraj Reddy Building Govindashetty – Palya Konnappana Agrahara Electronic Cit, Y, Bangalore, Karnataka, India – 560100.
Litman Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.